Aura Biosciences, Inc.AURANASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-25.56%
Near historical average
Percentile
P40
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-25.00%
Historical baseline
PeriodValue
2024-25.56%
2023-15.91%
2022-61.27%
2021-37.63%
2020-9.63%
20190.00%